The Drug That Halves Risk of Pancreatitis After ERCP Procedure

Rectal indomethacin, a common and inexpensive nonsteroidal anti-inflammatory drug, can cut the risk of pancreatitis after an ERCP procedure nearly in half.

Rectal indomethacin, a common and inexpensive nonsteroidal anti-inflammatory drug, can cut the risk of pancreatitis after an ERCP procedure nearly in half.

Some patients are now getting DNA tests before starting antidepressants because roughly 60 percent of people with depression do not benefit from the first...

For decades, the only meaningful treatment for hereditary transthyretin polyneuropathy was a liver transplant — a major surgical procedure that carried...

Low-dose aspirin, one of the cheapest and most widely available medications on the planet, is the drug that lowers the risk of preeclampsia in pregnant...

The gene silencing drug making headlines for its potential to treat a lifelong neurological condition with a single dose is called an RNA interference...

A new class of injectable therapies for hemophilia A has fundamentally changed what it means to live with the condition, replacing the grueling routine of...

Some cancer drugs now come with genetic testing requirements because certain patients carry gene variants that cause their bodies to metabolize these...

On March 10, 2026, the FDA approved Wellcovorin (leucovorin calcium) tablets as the first-ever treatment for cerebral folate transport deficiency caused...

A wave of new therapies for generalized myasthenia gravis is giving patients something they haven't had in decades: genuine relief from the crushing...

The drug generating the most excitement for actual cartilage regeneration in arthritic joints is sprifermin, a recombinant human fibroblast growth factor...